You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases.
|
|---|---|
| Published in |
Current Pharmaceutical Design, January 2017
|
| DOI | 10.2174/1381612823666170519151801 |
| Pubmed ID | |
| Authors |
Swathi Putta, Nagendra S. Yarla, Ilaria Peluso, Dinesh K. Tiwari, Gorla V. Reddy, Priyanka V. Giri, Naresh Kumar, Ramarao Malla, Vijaya Rachel, P. Veera Bramhachari, Rama S. Reddy D, Ramesh Bade, Mastan Mannarapu, George E. Barreto, Da-Yong Lu, Vadim V. Tarasov, Vladimir N. Chubarev, Frederico F. Ribeiro, Luciana Scotti, Marcus T. Scotti, M.A. Kamal, Ghulam Md Ashraf, Gjumrakch Aliev, George Perry, Satyajit D. Sarker, Chinthalapally V. Rao, Anupam Bishayee |
| Abstract |
Anthocyanins belong to the flavonoids class of polyphenols and they are water soluble dark colored natural pigments from fruits and vegetables. Dietary consumption of anthocyanins is high compared to other flavonoids, owing to their wide distribution in plant materials. Anthocyanins are the active component in several herbal folk medicines due to its multifaceted medicinal properties. This review discusses the anthocyanins as multitarget drugs, which posses antioxidant, antidiabetic, antihyperlipidemic, anti inflammatory, anticarcinogenic, antiulcer, cardioprotective, hepatoprotective, neuroprotective role. Several chemotherapeutic activities were observed in vitro and in vivo experimentation on cell-line studies, animal models, and clinical trials. This property of anthocyanins could be promising in providing health benefits against chronic diseases. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 60 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 7 | 12% |
| Researcher | 7 | 12% |
| Student > Bachelor | 7 | 12% |
| Student > Master | 6 | 10% |
| Professor | 4 | 7% |
| Other | 10 | 17% |
| Unknown | 19 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 8 | 13% |
| Agricultural and Biological Sciences | 6 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
| Chemistry | 4 | 7% |
| Medicine and Dentistry | 3 | 5% |
| Other | 11 | 18% |
| Unknown | 23 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2017.
All research outputs
#16,725,651
of 25,382,440 outputs
Outputs from Current Pharmaceutical Design
#2,431
of 3,701 outputs
Outputs of similar age
#255,106
of 421,709 outputs
Outputs of similar age from Current Pharmaceutical Design
#113
of 203 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,701 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,709 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 203 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.